‘Doubtful debt’ impacts Sigma earnings

Sigma has pointed to “doubtful debt” relating to one pharmacy group as having impacted its earnings before interest and tax during the last financial year Sigma Pharmaceuticals says it will announce its results for the full year ending 31 January 2017 on 23 March, but that it expects its underlying EBIT to be just over